The Swedish government recently announced that it plans to expand the country’s medical research to include breast cancer.

It is the latest example of the country expanding its efforts to combat the disease.

In the past, it has focused on breast cancer through a number of different programs, such as mammograms and prostate cancer screening.

But recently, the government has begun to look at the potential of cancer-specific research, and in the past two years it has launched a program that allows researchers to conduct breast and prostate biopsies.

The Swedish Breast Cancer Foundation, the body that oversees the countrys research programs, told The Huffington Store that this is a first step toward developing new drugs and treatments for breast cancer, but that it will take more time before we see the full impact of this effort.

This is the first time that Sweden has begun actively pursuing the research of breast cancer and it is important that we start now, said Kristin Kneemans, director of research and policy at the foundation.

The government announced that a total of 2,567 women and 521 men have been diagnosed with breast cancer in Sweden since 2007.

The number of men has increased slightly since 2007, with 2,967 diagnosed cases.

Since 2007, more than 20,000 men have died from the disease, and another 7,000 have been hospitalized for the disease’s complications.

In Sweden, breast cancer is typically diagnosed between the ages of 20 and 35, though some women also go on to develop it later in life.

In 2009, the country officially declared its first case of breast Cancer-specific gene therapy, which involves using DNA from a person’s genetic material to treat cancer.

The gene therapy is currently being tested on patients who are undergoing chemotherapy for cancer, according to The Associated Press.

While there are currently more than 1,000 gene therapy patients worldwide, Sweden is one of the few countries in the world where it is actually possible to receive the treatment.

The treatment has not yet been approved by the Food and Drug Administration.

This article has been updated to clarify that Sweden’s Breast Cancer Research Foundation operates out of its research center in Helsingborg, Sweden.